<?xml version="1.0" encoding="UTF-8"?><ValueSet xmlns="http://hl7.org/fhir"><id value="v3-substanceAdminSubstitution"/><meta><lastUpdated value="2018-08-12T00:00:00.000+00:00"/><profile value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/></meta><text><status value="generated"/><div xmlns="http://www.w3.org/1999/xhtml"><p>Release Date: 2018-08-12</p>
<table class="grid">
 <tr><td><b>Level</b></td><td><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr>
 <tr><td>1</td><td><span style="color: grey"><i>(_ActSubstanceAdminSubstitutionCode)</i></span> <b><i>Abstract</i></b></td><td><a name="v3-substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode">&#xA0;</a></td><td>
                        
                           Description: Substitution occurred or is permitted with another product that may potentially have different ingredients, but having the same biological and therapeutic effects.<br/>

                     </td></tr>
 <tr><td>2</td><td>&#xA0;&#xA0;E<a name="v3-substanceAdminSubstitution-E"> </a></td><td>equivalent</td><td>
                        
                           Description: Substitution occurred or is permitted with another bioequivalent and therapeutically equivalent product.<br/>

                     </td></tr>
 <tr><td>3</td><td>&#xA0;&#xA0;&#xA0;&#xA0;EC<a name="v3-substanceAdminSubstitution-EC"> </a></td><td>equivalent composition</td><td>
                        
                           Description: 
                        <br/>

                        Substitution occurred or is permitted with another product that is a:<br/>

                        
                           pharmaceutical alternative containing the same active ingredient but is formulated with different salt, ester
                           pharmaceutical equivalent that has the same active ingredient, strength, dosage form and route of administration
                        
                        
                           Examples: 
                        <br/>

                        
                           
                              Pharmaceutical alternative: Erythromycin Ethylsuccinate for Erythromycin Stearate
                           
                              Pharmaceutical equivalent: Lisonpril for Zestril
                        
                     </td></tr>
 <tr><td>4</td><td>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;BC<a name="v3-substanceAdminSubstitution-BC"> </a></td><td>brand composition</td><td>
                        
                           Description: 
                        <br/>

                        Substitution occurred or is permitted between equivalent Brands but not Generics<br/>

                        
                           Examples: 
                        <br/>

                        
                           Zestril  for Prinivil
                           Coumadin for Jantoven
                        
                     </td></tr>
 <tr><td>4</td><td>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;G<a name="v3-substanceAdminSubstitution-G"> </a></td><td>generic composition</td><td>
                        
                           Description: Substitution occurred or is permitted between equivalent Generics but not Brands<br/>

                        
                           Examples: 
                        <br/>

                        
                           Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
                        
                     </td></tr>
 <tr><td>3</td><td>&#xA0;&#xA0;&#xA0;&#xA0;TE<a name="v3-substanceAdminSubstitution-TE"> </a></td><td>therapeutic alternative</td><td>
                        
                           Description: Substitution occurred or is permitted with another product having the same therapeutic objective and safety profile.<br/>

                        
                           Examples: 
                        <br/>

                        
                           ranitidine for Tagamet
                        
                     </td></tr>
 <tr><td>4</td><td>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;TB<a name="v3-substanceAdminSubstitution-TB"> </a></td><td>therapeutic brand</td><td>
                        
                           Description: Substitution occurred or is permitted between therapeutically equivalent Brands but not Generics<br/>
&gt;
                           Examples: 
                        <br/>

                        
                           Zantac for Tagamet
                        
                     </td></tr>
 <tr><td>4</td><td>&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;TG<a name="v3-substanceAdminSubstitution-TG"> </a></td><td>therapeutic generic</td><td>
                        
                           Description: Substitution occurred or is permitted between therapeutically equivalent Generics but not Brands<br/>
&gt;
                           Examples: 
                        <br/>

                        
                           Ranitidine  for cimetidine
                        
                     </td></tr>
 <tr><td>2</td><td>&#xA0;&#xA0;F<a name="v3-substanceAdminSubstitution-F"> </a></td><td>formulary</td><td>
                        
                           Description: This substitution was performed or is permitted based on formulary guidelines. <br/>

                     </td></tr>
 <tr><td>2</td><td>&#xA0;&#xA0;N<a name="v3-substanceAdminSubstitution-N"> </a></td><td>none</td><td>
                        No substitution occurred or is permitted.<br/>

                     </td></tr>
</table>
</div></text><extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"><valueCode value="external"/></extension><extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"><valueInteger value="0"/></extension><extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg"><valueCode value="vocab"/></extension><url value="http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution"/><version value="2018-08-12"/><name value="v3.substanceAdminSubstitution"/><title value="v3 Code System substanceAdminSubstitution"/><status value="active"/><experimental value="false"/><date value="2018-08-12"/><publisher value="HL7, Inc"/><contact><telecom><system value="url"/><value value="http://hl7.org"/></telecom></contact><description value=" Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided."/><immutable value="true"/><compose><include><system value="http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution"/></include></compose></ValueSet>